Literature DB >> 6368058

Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis.

R M Bernstein, J M Neuberger, C C Bunn, M E Callender, G R Hughes, R Williams.   

Abstract

The presence of autoantibodies in the serum of 110 patients with primary biliary cirrhosis (PBC), 50 with HBsAg negative chronic active hepatitis (HBsAg- CAH) and 30 with HBsAg positive chronic active hepatitis (HBsAg+ CAH) was assessed using two methods: indirect immunofluorescence on cells grown in tissue culture (HEp-2 cell line) or standard mouse tissue sections, and counter immunoelectrophoresis (CIE) with soluble tissue extracts. Anti-nuclear antibodies (ANA) were found in 38% of sera from patients with PBC using HEp-2 cells compared with 10% using mouse tissue. A variety of staining patterns were detected including a pattern of multiple nuclear dots. In contrast, ANA was detected in 70% of sera from patients with HBsAg- CAH and 27% with HBsAg+ CAH. Using CIE four distinct antibody antigen systems were detected: Ro (SS-A), La (SS-B) and two new systems, designated XH and XR, reacting with extracts of human spleen and rabbit thymus, respectively. Correlation of the presence of antibody with clinical conditions confirmed the close association between anti-centromere antibody and sclerodactyly in patients with PBC and indicated an association between 'multiple nuclear dot' staining and the sicca syndrome in PBC. No association was found between the presence of either Ro or La antibody and the sicca syndrome in patients with PBC.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6368058      PMCID: PMC1535919     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Resolution of the identity of certain antigen-antibody systems in systemic lupus erythematosus and Sjögren's syndrome: an interlaboratory collaboration.

Authors:  M Alspaugh; P Maddison
Journal:  Arthritis Rheum       Date:  1979-07

2.  Genetic differences between primary and secondary sicca syndrome.

Authors:  H M Moutsopoulos; D L Mann; A H Johnson; T M Chused
Journal:  N Engl J Med       Date:  1979-10-04       Impact factor: 91.245

3.  Antinuclear antibodies. I. Patterns of nuclear immunofluorescence.

Authors:  T K Burnham; P W Bank
Journal:  J Invest Dermatol       Date:  1974-05       Impact factor: 8.551

4.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

5.  Tissue antibodies in primary biliary cirrhosis, active chronic (lupoid) hepatitis, cryptogenic cirrhosis and other liver diseases and their clinical implications.

Authors:  D Doniach; I M Roitt; J G Walker; S Sherlock
Journal:  Clin Exp Immunol       Date:  1966-07       Impact factor: 4.330

6.  Preciitating antibodies to mitochondrial antigens in patients with primary biliary cirrhosis.

Authors:  K Miyachi; R C Gupta; E R Dickson; E M Tan
Journal:  Clin Exp Immunol       Date:  1980-03       Impact factor: 4.330

7.  Association of antinuclear and antinucleolar antibodies in progressive systemic sclerosis.

Authors:  R M Bernstein; J C Steigerwald; E M Tan
Journal:  Clin Exp Immunol       Date:  1982-04       Impact factor: 4.330

8.  Primary or secondary sicca complex? Investigation in primary biliary cirrhosis by histocompatibility testing.

Authors:  A N Hamlyn; D Adams; S Sherlock
Journal:  Br Med J       Date:  1980-08-09

Review 9.  Nuclear non-chromatin proteinaceous structures: their role in the organization and function of the interphase nucleus.

Authors:  P S Agutter; J C Richardson
Journal:  J Cell Sci       Date:  1980-08       Impact factor: 5.285

10.  Distribution of kinetochore (centromere) antigen in mammalian cell nuclei.

Authors:  Y Moroi; A L Hartman; P K Nakane; E M Tan
Journal:  J Cell Biol       Date:  1981-07       Impact factor: 10.539

View more
  32 in total

1.  Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis.

Authors:  E I Rigopoulou; E T Davies; A Pares; K Zachou; C Liaskos; D-P Bogdanos; J Rodes; G N Dalekos; D Vergani
Journal:  Gut       Date:  2005-04       Impact factor: 23.059

Review 2.  Primary biliary cirrhosis.

Authors:  J Neuberger; M Lombard; R Galbraith
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  Nuclear membrane-staining antinuclear antibody in patients with primary biliary cirrhosis.

Authors:  A Ruffatti; P Arslan; A Floreani; G De Silvestro; A Calligaro; R Naccarato; S Todesco
Journal:  J Clin Immunol       Date:  1985-09       Impact factor: 8.317

Review 4.  Nature of autoantigens and autoantibodies in autoimmune hepatitis.

Authors:  M P Manns; K H Meyer zum Büschenfelde
Journal:  Springer Semin Immunopathol       Date:  1990

Review 5.  Autoantibodies in primary biliary cirrhosis.

Authors:  P A Berg; R Klein
Journal:  Springer Semin Immunopathol       Date:  1990

6.  Autoimmune cholangitis.

Authors:  J Heathcote
Journal:  Gut       Date:  1997-04       Impact factor: 23.059

7.  The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore.

Authors:  J C Courvalin; K Lassoued; E Bartnik; G Blobel; R W Wozniak
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

8.  Immunomorphological characterisation of antinuclear antibodies in chronic liver disease.

Authors:  F Cassani; F B Bianchi; M Lenzi; U Volta; E Pisi
Journal:  J Clin Pathol       Date:  1985-07       Impact factor: 3.411

9.  Specificity of antinuclear antibodies in primary biliary cirrhosis.

Authors:  M J Chou; S L Lee; T Y Chen; G J Tsay
Journal:  Ann Rheum Dis       Date:  1995-02       Impact factor: 19.103

10.  Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis.

Authors:  P Michieletti; I R Wanless; A Katz; P J Scheuer; S J Yeaman; M F Bassendine; J M Palmer; E J Heathcote
Journal:  Gut       Date:  1994-02       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.